Annual Total Liabilities
$11.04 M
-$7.47 M-40.36%
December 1, 2023
Summary
- As of February 7, 2025, ZVSA annual total liabilities is $11.04 million, with the most recent change of -$7.47 million (-40.36%) on December 1, 2023.
- During the last 3 years, ZVSA annual total liabilities has risen by +$1.80 million (+19.43%).
- ZVSA annual total liabilities is now -40.36% below its all-time high of $18.51 million, reached on December 31, 2022.
Performance
ZVSA Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$12.40 M
+$1.55 M+14.26%
September 1, 2024
Summary
- As of February 7, 2025, ZVSA quarterly total liabilities is $12.40 million, with the most recent change of +$1.55 million (+14.26%) on September 1, 2024.
- Over the past year, ZVSA quarterly total liabilities has increased by +$1.97 million (+18.88%).
- ZVSA quarterly total liabilities is now -33.03% below its all-time high of $18.51 million, reached on December 31, 2022.
Performance
ZVSA Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ZVSA Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -40.4% | +18.9% |
| 3 y3 years | +19.4% | -27.8% |
| 5 y5 years | +19.4% | -27.8% |
ZVSA Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -40.4% | at low | -33.0% | +18.9% |
| 5 y | 5-year | -40.4% | +19.4% | -33.0% | +18.9% |
| alltime | all time | -40.4% | +19.4% | -33.0% | +18.9% |
ZyVersa Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $12.40 M(+14.3%) |
| Jun 2024 | - | $10.85 M(+4.0%) |
| Mar 2024 | - | $10.43 M(-5.5%) |
| Dec 2023 | $11.04 M | $11.04 M(-16.0%) |
| Sep 2023 | - | $13.15 M(+10.2%) |
| Jun 2023 | - | $11.93 M(-33.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $17.86 M(-3.5%) |
| Dec 2022 | $18.51 M(+35.9%) | $18.51 M(+30.8%) |
| Sep 2022 | - | $14.15 M(-17.5%) |
| Jun 2022 | - | $17.16 M(+25.9%) |
| Dec 2021 | $13.63 M(+47.4%) | - |
| Dec 2021 | - | $13.63 M |
| Dec 2020 | $9.24 M | - |
FAQ
- What is ZyVersa Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for ZyVersa Therapeutics?
- What is ZyVersa Therapeutics annual total liabilities year-on-year change?
- What is ZyVersa Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for ZyVersa Therapeutics?
- What is ZyVersa Therapeutics quarterly total liabilities year-on-year change?
What is ZyVersa Therapeutics annual total liabilities?
The current annual total liabilities of ZVSA is $11.04 M
What is the all time high annual total liabilities for ZyVersa Therapeutics?
ZyVersa Therapeutics all-time high annual total liabilities is $18.51 M
What is ZyVersa Therapeutics annual total liabilities year-on-year change?
Over the past year, ZVSA annual total liabilities has changed by -$7.47 M (-40.36%)
What is ZyVersa Therapeutics quarterly total liabilities?
The current quarterly total liabilities of ZVSA is $12.40 M
What is the all time high quarterly total liabilities for ZyVersa Therapeutics?
ZyVersa Therapeutics all-time high quarterly total liabilities is $18.51 M
What is ZyVersa Therapeutics quarterly total liabilities year-on-year change?
Over the past year, ZVSA quarterly total liabilities has changed by +$1.97 M (+18.88%)